Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

SearchMedicare Part D Search Results « » The Henry J. Kaiser Family Foundation

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
The Henry J. Kaiser Family Foundation

Medicare: The Essentials

Slideshow Read More
The Henry J. Kaiser Family Foundation

Medicare Part D 2010 Data Spotlight: Prices for Brand-Name Drugs in the Coverage Gap

This Medicare Part D data spotlight finds prices for some commonly used brand-name drugs rising in 2010 for beneficiaries who reach the coverage gap (or “doughnut hole”), with increases since 2006 far exceeding the growth in inflation.

Issue Brief Read More
The Henry J. Kaiser Family Foundation

The Medicare Part D Coverage Gap: Costs and Consequences in 2007

This study quantifies the number of Medicare Part D plan enrollees in 2007 who reached a gap in their prescription drug coverage known as the “doughnut hole,” as well as the changes in beneficiaries’ use of medications and out-of-pocket spending after they reached that gap.

Report Read More
medicare_cost-sharing-drugs_line_TEST

Medicare Part D in Its Ninth Year: The 2014 Marketplace and Key Trends, 2006-2014

This report presents findings from an analysis of the Medicare Part D marketplace in 2014 and changes in features of the drug benefit offered by Part D plans since 2006. It examines the latest information and trends related to Part D enrollment and plan availability, premiums, benefit design and cost sharing, pharmacy networks, the Low-Income Subsidy Program, and plan performance ratings.

Report Read More
The Henry J. Kaiser Family Foundation

Medicare Part D Prescription Drug Plans: The Marketplace in 2013 and Key Trends, 2006-2013

This report presents findings from an analysis of the Medicare Part D marketplace in 2013 and changes in drug coverage and costs since 2006. It presents key findings related to Medicare drug plan availability, enrollment, premiums, low-income subsidies, the coverage gap, benefit design, cost sharing, formularies, and utilization management, based on data from CMS for all plans participating in Part D. The analysis was conducted jointly by researchers at Georgetown University, the Kaiser Family Foundation and the National Opinion Research Center at the University of Chicago.

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Medicare Part D: A First Look at Plan Offerings in 2015

This issue brief provides an overview of the Medicare Part D stand-alone prescription drug plan options available in 2015 and key changes from prior years. The analysis examines Part D plan availability, premiums, benefit design features, and low income subsidy plan availability.

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Report Examines Trends in the Medicare Part D Plan Marketplace

A new comprehensive Kaiser Family Foundation report analyzes key trends that have shaped the Medicare Part D marketplace since the program launched nine years ago, providing a detailed assessment of changes in plan availability, enrollment, premiums and cost sharing in both private stand-alone drug plans, and Medicare Advantage drug plans.

News Release Read More
The Henry J. Kaiser Family Foundation

Open Enrollment: Insights from Medicare for Health Insurance Marketplaces

This Policy Insight draws on the experiences of Medicare beneficiaries during Medicare’s annual enrollment period to consider whether consumers with health insurance coverage through the Affordable Care Act’s new marketplaces will shop for a better deal during their open enrollment season.

Perspective Read More
The Henry J. Kaiser Family Foundation

Open Enrollment: Insights from Medicare for Health Insurance Marketplaces

In the latest post in the Policy Insights series, Tricia Neuman draws on the experiences of Medicare beneficiaries during Medicare’s annual enrollment period to consider whether consumers with health insurance coverage through the Affordable Care Act’s new marketplaces will shop for a better deal during their open enrollment season. Previous columns in the Policy Insights series…

News Release Read More
The Henry J. Kaiser Family Foundation

Health Affairs Blog: The Cost of A Cure: Medicare’s Role in Treating Hepatitis C

This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.

Perspective Read More